![René Rückert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
René Rückert
Direttore operativo presso Isarna Therapeutics GmbH
Provenienza dei contatti di primo grado di René Rückert
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Isarna Therapeutics GmbH
![]() Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany.
3
| Holding Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a René Rückert tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
WIRECARD AG | Regional Banks | Comptroller/Controller/Auditor | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arthur Andersen LLP
![]() Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Colorado State University | College/University | Masters Business Admin | |
Ruprecht-Karls-Universität Heidelberg | College/University | Corporate Officer/Principal | |
University of Bamberg | College/University | Masters Business Admin | |
PIERIS PHARMACEUTICALS, INC. | Biotechnology | Founder | |
Anavo Therapeutics BV
![]() Anavo Therapeutics BV BiotechnologyHealth Technology Anavo Therapeutics BV is a Dutch company that specializes in developing first-in-class therapeutic programs for several indications in oncology. The company is based in Leiden, Netherlands. The company has attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. Anavo is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. Anavo is backed by blue-chip investors m ventures, inkef capital, taiho ventures, mrl ventures fund, and bioqube ventures. The company was founded by Claus Schalper, Birgit Zech, Gerhard Müller. Birgit Zech has been the CEO since incorporation. | Biotechnology | Founder | |
Merck Serono SA
![]() Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Germania | 5 |
Regno Unito | 2 |
Paesi Bassi | 2 |
Svizzera | 2 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Commercial Services | 2 |
Posizioni
Corporate Officer/Principal | 6 |
Founder | 4 |
Director of Finance/CFO | 3 |
Chief Executive Officer | 3 |
Masters Business Admin | 2 |
Contatti più connessi
Insiders | |
---|---|
Claus Schalper | 8 |
Eugen Leo | 6 |
Chris Huiskamp | 1 |
- Borsa valori
- Insiders
- René Rückert
- Connessioni Società